Tutorials
Johnson & Johnson logo

Johnson & Johnson

$ 171.11 -0.68 (-0.4%) 10:08 PM EST
On watch
P/E:
24.91
P/B:
5.89
Market Cap:
$ 449.88B
Enterprise V:
$ 449.91B
Volume:
5.21M
Avg Vol (2M):
6.58M
Also Trade In:
Volume:
5.21M
Market Cap $:
449.88B
PE Ratio:
24.91
Avg Vol (2-Month):
6.58M
Enterprise Value $:
449.91B
PB Ratio:
5.89
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Johnson & Johnson
NAICS : 325412 SIC : 2834
One Johnson and Johnson Plaza, New Brunswick, NJ, USA, 08933
Description
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total revenue is generated in the United States.

Financials (Next Earnings Date:2022-10-19 Est.)

JNJ's 30-Y Financials

Johnson & Johnson Operating Data

JNJ's Complete Operating Data
No operating data availabel for Johnson & Johnson.

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NYSE:JNJ

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 95,588
EPS (TTM) ($) 6.87
Beta 0.55
Volatility % 15.99
14-Day RSI 40.28
14-Day ATR ($) 2.832813
20-Day SMA ($) 173.7995
12-1 Month Momentum % 2.56
52-Week Range ($) 155.72 - 186.69
Shares Outstanding (Mil) 2,629.18

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Johnson & Johnson Filings

Document Form Filing Date
No Filing Data

Headlines

See More